https://research.uniupo.it/en/publications/incidence-and-severity-of-immune-related-hepatitis-after-dual-che/
Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to...
checkpoint therapyincidenceseverityimmunerelated
https://www.fiercebiotech.com/editorial/leading-immune-checkpoint-therapy-trials-in-nsclc-at-md-anderson
Leading Immune Checkpoint Therapy Trials in NSCLC, at MD Anderson
Jan 28, 2022 - Dr Cascone speaks about identifying mechanisms of response and resistance to immunotherapies and developing novel therapeutic strategies in non-small cell lung...
immune checkpointmd andersonleadingtherapytrials